Is a complete TPEX/6621 research report available?

No complete published report is available for tpex/6621 (TPEX/6621) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TPEX/6621 (TPEX/6621)

Taipei Exchange: TPEX/6621 · TWD

NT$11.6

-0.05 (-0.4%)· Recorded snapshot

Market cap	410M
Revenue (ttm)	83.9M
Net income (ttm)	-40.1M
EPS (ttm)	-NT$1.13
Shares out	35.5M
Volume	10,171
Beta	-0.22

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 83.9M
Net income (ttm): -40.1M
EPS (ttm): -NT$1.13
Market cap: 410M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All TPEX/6621 indicators

Market & fundamental data

Available fields

176

Groups with data

Currency

TWD

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	34
Employees Change	3%
Employees Change Percent	9.68
Enterprise value	TWD 314.8M
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	40.55
Isin	TW0006621006
Last refreshed	2026-09-13
Market cap	TWD 410M
Price	TWD 11.55
Price currency	TWD
Sector	Healthcare
Sector PE	88.31
Sector PE Fwd	27.72
Sic	5047
Symbol	tpex/6621
Website	https://www.uni-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.78%
EV/Sales	3.75x
FCF yield	-8.53%
P/B ratio	2.08x
P/S ratio	4.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-54.6%
EBITDA Margin	-50.81%
Gross margin	50.86%
Gross Profit	TWD 42.7M
Gross Profit Growth	-10.3%
Gross Profit Growth Q	-19.54%
Gross Profit Growth3 Y	-15.28%
Gross Profit Growth5 Y	-5.72%
Net Income	TWD -40.1M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-47.8%
Profit Margin	-47.8%
ROA	-10.86
Roa5y	-6.04
ROCE	-22.53
ROE	-17.9
Roe5y	-11.1
ROIC	-45.1
Roic5y	-22.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-14.51%
Cagr3y	-13.49%
Cagr5y	-1.21%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-7.62x
Revenue Growth Q	-10.32x
Revenue Growth Qo Q	-9.93x
Revenue Growth Years	0x
Revenue Growth3 Y	-12.29x
Revenue Growth5 Y	-6.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.32
Assets	TWD 235.3M
Cash	TWD 107.6M
Current Assets	TWD 155.2M
Current Liabilities	TWD 32M
Debt	TWD 12.3M
Debt Equity	TWD 0.06
Debt FCF	TWD -0.35
Equity	TWD 196.8M
Interest Coverage	-293.6
Liabilities	TWD 38.5M
Long Term Assets	TWD 80.1M
Long Term Liabilities	TWD 6.5M
Net Cash	TWD 95.3M
Net Cash By Market Cap	TWD 23.23
Net Cash Growth	-27.73%
Net Debt Equity	TWD -0.48
Tangible Book Value	TWD 193.6M
Tangible Book Value Per Share	TWD 5.45
WACC	2.96

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.85
Inventory Turnover	1.41
Net Working Capital	TWD 21.4M
Quick ratio	3.77
Working Capital	TWD 123.2M
Working Capital Turnover	TWD 0.59

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-14.5%
200-day SMA	12.16
3Y total return	-35.26%
50-day SMA	11.33
50-day SMA vs 200-day SMA	50under200
5Y total return	-5.88%
All Time High	93
All Time High Change	-87.96%
All Time High Date	2020-07-08
All Time Low	6.19
All Time Low Change	80.94%
All Time Low Date	2020-03-19
ATR	0.46
Beta	-0.22
Beta1y	0.05
Beta2y	0.1
Ch YTD	-7.82
High	11.55
High52	16
High52 Date	2026-04-23
High52ch	-27.81%
Low	11.2
Low52	10.6
Low52 Date	2026-08-10
Low52ch	8.96%
Ma50ch	-1.1%
Price vs 200-day SMA	-7.9%
RSI	46.25
RSI Monthly	40.47
RSI Weekly	41.83
Sharpe ratio	-0.16x
Sharpe Ratio3y	-0.2x
Sharpe Ratio5y	0.11x
Sortino ratio	-0.11
Sortino Ratio3y	-0.21
Sortino Ratio5y	0.34
Tr YTD	-7.82
Tr1m	5.16%
Tr1w	-2.18%
Tr3m	-2.18%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,153,810%
Net Borrowing	-4,743,000
Shares Insiders	2.28%
Shares Out	35,501,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	44,156.5x
Bv Per Share	5.54
CAPEX	TWD -1.2M
Ch1m	5.16
Ch1w	-2.18
Ch1y	-14.5
Ch3m	-2.18
Ch3y	-35.26
Ch5y	-5.88
Ch6m	-10.04
Change	-0.43%
Change From Open	3.13
Close	11.6
Days Gap	-3.45
Depreciation Amortization	3,175,000
Dollar Volume	117,475.1
Earnings Date	2026-11-13
EBIT	TWD -45.8M
EBITDA	TWD -42.6M
EPS	TWD -1.13
F Score	2
FCF	TWD -35M
FCF EV Yield	-11.11x
FCF Per Share	TWD -0.99
Financing CF	-4,743,000
Fiscal Year End	December
Founded	1,998
Investing CF	12,532,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2026-06-30
Ma150	12.09
Ma150ch	-7.38%
Ma20	11.41
Ma20ch	-1.84%
Net CF	-26,037,000
Next Earnings Date	2026-11-13
Open	11.2
Position In Range	100
Ppne	19,095,000
Price Date	2026-09-11
Ptbv Ratio	2.12
Relative Volume	0.23x
Revenue	83,872,000x
Tr6m	-10.04%
Volume	10,171
Z Score	6.4

TPEX/6621 (TPEX/6621)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/6621

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/6621 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/6621

Frequently asked questions